MT-ND5 and cancer: Figure 14, Figure 15 and Figure 16 illustrate the changes in nuclear morphology and F-actin organization in A375, MCF-7, and PANC-1 cancer cells after 48 h treatment with Nd0-Nd5 at two representative concentrations: 500 and 1000 μg·mL−1.